Renovaro Biosciences Inc banner
R

Renovaro Biosciences Inc
NASDAQ:RENB

Watchlist Manager
Renovaro Biosciences Inc
NASDAQ:RENB
Watchlist
Price: 1.266 USD
Market Cap: $29.3m

During the last 3 months Renovaro Biosciences Inc insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Jul 29, 2024 by William Anderson Wittekind , who sold 1.4k USD worth of RENB shares.

Last Transactions:
William Anderson Wittekind
$-144.3
William Anderson Wittekind
$-23.9k
William Anderson Wittekind
$-31k
William Anderson Wittekind
$-22.5k
William Anderson Wittekind
$-113.3k
William Anderson Wittekind
$-7.1k
William Anderson Wittekind
$-93k
William Anderson Wittekind
$-75.5k
William Anderson Wittekind
$-53.2k
William Anderson Wittekind
$-93.6k
William Anderson Wittekind
$-22k
William Anderson Wittekind
$-78.5k
William Anderson Wittekind
$-31.6k
William Anderson Wittekind
$-79k
Gumrukcu Serhat
$-1m
Sindlev Rene
$+1m
Sandler Carl Forest
$-17.5k
Sandler Carl Forest
$-54
Sandler Carl Forest
$-61.3k
Sindlev Rene
$+211.1k
Sindlev Rene
$+268k
Sindlev Rene
$+132k
Sindlev Rene
$+239.3k
Sindlev Rene
$+31.3k
Sindlev Rene
$+2.9k
Sindlev Rene
$+115k
Gronfeldt-Sorensen Henrik
$+100k
Leire, Eric Jean Marie
$+1.1k
Leire, Eric Jean Marie
$+1.6k
Leire, Eric Jean Marie
$+4.1k
Leire, Eric Jean Marie
$+1k
Sindlev Rene
$+500k
View All Transactions

During the last 3 months Renovaro Biosciences Inc insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Jul 29, 2024 by William Anderson Wittekind , who sold 1.4k USD worth of RENB shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Renovaro Biosciences Inc
Insider Trading Chart

Renovaro Biosciences Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Renovaro Biosciences Inc
Last Insider Transactions

Global
Insiders Monitor

Renovaro Biosciences Inc
Glance View

Market Cap
29.3m USD
Industry
Biotechnology

Enochian Biosciences, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. The company is headquartered in Los Angeles, California and currently employs 11 full-time employees. The company went IPO on 2014-11-18. The company is focused on developing allogeneic cell and gene therapies to promote stronger immune system responses for long-term or life-long cancer remission in cancers and to treat or cure infectious diseases, such as Human Immunodeficiency Virus (HIV) and Hepatitis B virus (HBV) infection. The Allogeneic Cell Therapy platform has a human immune system, which is designed to recognize the self and destroy otherness or non-self, such as bacteria, viruses and cancer cells. Its product candidates include ENOB-HV-01, which utilizes a cellular- and immunotherapy approach that could provide both preventative and therapeutic vaccines for HIV and ENOB-DC-11, which is a genetically modified allogeneic dendritic cell therapeutic vaccine as product for long-term remission of solid tumors. The company is also exploring ENOB-HV-21, a treatment for HIV with allogeneic natural killer and gamma delta t-cells.

RENB Intrinsic Value
0.07 USD
Overvaluation 94%
Intrinsic Value
Price $1.266
R

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett